Januari 2012
31
Somaraju UR, and Merrin M. 2010. Sapropterin dihydrochloride for phenylketonuria. Cochrane
Database Syst RevCD008005.
ten Hoedt AE, de Sonneville LM, Francois B, ter Horst NM, Janssen MC, Rubio-Gozalbo ME, Wijburg
FA, Hollak CE, and Bosch AM. 2011. High phenylalanine levels directly affect mood and sustained
attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled,
crossover trial. J Inherit Metab Dis 34:165-171.
Trefz FK, Burton BK, Longo N, Casanova MM, Gruskin DJ, Dorenbaum A, Kakkis ED, Crombez EA,
Grange DK, Harmatz P, Lipson MH, Milanowski A, Randolph LM, Vockley J, Whitley CB, Wolff JA,
Bebchuk J, Christ-Schmidt H, and Hennermann JB. 2009. Efficacy of sapropterin dihydrochloride in
increasing phenylalanine tolerance in children with phenylketonuria: a phase III, randomized,
double-blind, placebo-controlled study. J Pediatr 154:700-707.
van Rijn M, Bekhof J, Dijkstra T, Smit PG, Moddermam P, and van Spronsen FJ. 2003. A different
approach to breast-feeding of the infant with phenylketonuria. Eur J Pediatr 162:323-326.
van Spronsen FJ, Verkerk PH, van HM, Smit GP, van der Meer SB, Bakker HD, and Sengers RC. 1997.
Does impaired growth of PKU patients correlate with the strictness of dietary treatment? National
Dutch PKU Steering Committee. Acta Paediatr 86:816-818.
Waisbren SE, Noel K, Fahrbach K, Cella C, Frame D, Dorenbaum A, and Levy H. 2007. Phenylalanine
blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-
analysis. Mol Genet Metab 92:63-70.
Williams RA, Mamotte CD, and Burnett JR. 2008. Phenylketonuria: an inborn error of phenylalanine
metabolism. Clin Biochem Rev 29:31-41.